lnflammation-induced epigenetic switches in cancer

Area of Science:

• Oncology
• Epigenetics
• Immunology

Background:

• The link between chronic inflammation and cancer development is well-documented.
• Inflammation is recognized as a key driver in cancer initiation and progression.
• Epigenetic alterations are increasingly understood as crucial mechanisms underlying this link.

Purpose of the Study:

• To review existing evidence on epigenetic switches in inflammation-induced cancer.
• To elucidate the role of inflammation as an initiating event for epigenetic alterations.
• To highlight the potential of targeting epigenetic switches for novel cancer therapeutics.

Main Methods:

• Literature review of studies investigating inflammation, epigenetics, and cancer.
• Analysis of mechanisms including DNA methylation, histone modifications, and regulatory networks.
• Synthesis of evidence linking inflammation to the induction and maintenance of epigenetic switches.

Main Results:

• Chronic inflammation can induce "epigenetic switches" that drive malignant transformation.
• These switches involve epigenetic modifications (DNA methylation, histone changes) and regulatory factors (PcG/TrxG proteins, miRNA-TF loops).
• The resulting cellular phenotype is stably inherited even after the initial inflammatory trigger is removed.

Conclusions:

• Epigenetic switches are critical mediators of inflammation-driven cancer.
• The reversibility of epigenetic switches presents a promising avenue for developing innovative anticancer treatments.
• Targeting these inflammation-induced epigenetic changes could offer new therapeutic strategies.